405 related articles for article (PubMed ID: 28671018)
41. Estrogenic gper signaling regulates mir144 expression in cancer cells and cancer-associated fibroblasts (cafs).
Vivacqua A; De Marco P; Santolla MF; Cirillo F; Pellegrino M; Panno ML; Abonante S; Maggiolini M
Oncotarget; 2015 Jun; 6(18):16573-87. PubMed ID: 26030000
[TBL] [Abstract][Full Text] [Related]
42. GPER and Testicular Germ Cell Cancer.
Chevalier N; Hinault C; Clavel S; Paul-Bellon R; Fenichel P
Front Endocrinol (Lausanne); 2020; 11():600404. PubMed ID: 33574796
[TBL] [Abstract][Full Text] [Related]
43. Homology Modeling, Validation and Dynamics of the G Protein-coupled Estrogen Receptor 1 (GPER-1).
Bruno A; Aiello F; Costantino G; Radi M
Mol Inform; 2016 Sep; 35(8-9):333-9. PubMed ID: 27546037
[TBL] [Abstract][Full Text] [Related]
44. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
Grabinski N; Möllmann K; Milde-Langosch K; Müller V; Schumacher U; Brandt B; Pantel K; Jücker M
Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007
[TBL] [Abstract][Full Text] [Related]
45. GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells.
Vivacqua A; Romeo E; De Marco P; De Francesco EM; Abonante S; Maggiolini M
Breast Cancer Res Treat; 2012 Jun; 133(3):1025-35. PubMed ID: 22147081
[TBL] [Abstract][Full Text] [Related]
46. Not lost in translation: Emerging clinical importance of the G protein-coupled estrogen receptor GPER.
Barton M
Steroids; 2016 Jul; 111():37-45. PubMed ID: 26921679
[TBL] [Abstract][Full Text] [Related]
47. Role of GPER on proliferation, migration and invasion in ligand-independent manner in human ovarian cancer cell line SKOV3.
Yan Y; Jiang X; Zhao Y; Wen H; Liu G
Cell Biochem Funct; 2015 Dec; 33(8):552-9. PubMed ID: 26526233
[TBL] [Abstract][Full Text] [Related]
48. The G protein-coupled estrogen receptor (GPER) is expressed in two different subcellular localizations reflecting distinct tumor properties in breast cancer.
Samartzis EP; Noske A; Meisel A; Varga Z; Fink D; Imesch P
PLoS One; 2014; 9(1):e83296. PubMed ID: 24421881
[TBL] [Abstract][Full Text] [Related]
49. Estrogen receptors as potential therapeutic target in endometrial cancer.
Guha P; Sen K; Chowdhury P; Mukherjee D
J Recept Signal Transduct Res; 2023 Feb; 43(1):19-26. PubMed ID: 36883690
[TBL] [Abstract][Full Text] [Related]
50. Insulin-like growth factor-I regulates GPER expression and function in cancer cells.
De Marco P; Bartella V; Vivacqua A; Lappano R; Santolla MF; Morcavallo A; Pezzi V; Belfiore A; Maggiolini M
Oncogene; 2013 Feb; 32(6):678-88. PubMed ID: 22430216
[TBL] [Abstract][Full Text] [Related]
51. The G Protein-Coupled Estrogen Receptor (GPER) Expression Correlates with Pro-Metastatic Pathways in ER-Negative Breast Cancer: A Bioinformatics Analysis.
Talia M; De Francesco EM; Rigiracciolo DC; Muoio MG; Muglia L; Belfiore A; Maggiolini M; Sims AH; Lappano R
Cells; 2020 Mar; 9(3):. PubMed ID: 32143514
[TBL] [Abstract][Full Text] [Related]
52. A genetic polymorphism repurposes the G-protein coupled and membrane-associated estrogen receptor GPER to a transcription factor-like molecule promoting paracrine signaling between stroma and breast carcinoma cells.
Pupo M; Bodmer A; Berto M; Maggiolini M; Dietrich PY; Picard D
Oncotarget; 2017 Jul; 8(29):46728-46744. PubMed ID: 28596490
[TBL] [Abstract][Full Text] [Related]
53. Retrograde transport of the transmembrane estrogen receptor, G-protein-coupled-receptor-30 (GPR30/GPER) from the plasma membrane towards the nucleus.
Cheng SB; Graeber CT; Quinn JA; Filardo EJ
Steroids; 2011 Aug; 76(9):892-6. PubMed ID: 21354433
[TBL] [Abstract][Full Text] [Related]
54. GPER and ERα expression in abnormal endometrial proliferations.
Tica AA; Tica OS; Georgescu CV; Pirici D; Bogdan M; Ciurea T; Mogoantă SŞ; Georgescu CC; Comănescu AC; Bălşeanu TA; Ciurea RN; Osiac E; Buga AM; Ciurea ME
Rom J Morphol Embryol; 2016; 57(2):413-8. PubMed ID: 27516013
[TBL] [Abstract][Full Text] [Related]
55. Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER.
Girgert R; Emons G; Gründker C
Front Endocrinol (Lausanne); 2018; 9():781. PubMed ID: 30687231
[TBL] [Abstract][Full Text] [Related]
56. G-Protein Coupled Estrogen Receptor in Breast Cancer.
Hsu LH; Chu NM; Lin YF; Kao SH
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30646517
[TBL] [Abstract][Full Text] [Related]
57. Synthesis and characterization of tricarbonyl-Re/Tc(I) chelate probes targeting the G protein-coupled estrogen receptor GPER/GPR30.
Burai R; Ramesh C; Nayak TK; Dennis MK; Bryant BK; Prossnitz ER; Arterburn JB
PLoS One; 2012; 7(10):e46861. PubMed ID: 23077529
[TBL] [Abstract][Full Text] [Related]
58. GPER mediates estrogen-induced signaling and proliferation in human breast epithelial cells and normal and malignant breast.
Scaling AL; Prossnitz ER; Hathaway HJ
Horm Cancer; 2014 Jun; 5(3):146-160. PubMed ID: 24718936
[TBL] [Abstract][Full Text] [Related]
59. The G Protein-Coupled Estrogen Receptor (GPER): A Critical Therapeutic Target for Cancer.
Hall KA; Filardo EJ
Cells; 2023 Oct; 12(20):. PubMed ID: 37887304
[TBL] [Abstract][Full Text] [Related]
60. Enhanced expression of G-protein coupled estrogen receptor (GPER/GPR30) in lung cancer.
Jala VR; Radde BN; Haribabu B; Klinge CM
BMC Cancer; 2012 Dec; 12():624. PubMed ID: 23273253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
